Recently stock market analysts have updated their consensus ratings on shares of Amedica Co. (AMDA). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

01/05/2016 – Ladenburg Thalmann began new coverage on Amedica Co. giving the company a “buy” rating. They now have a USD 0.35 price target on the stock.

11/13/2015 – Amedica Co. had its “buy” rating reiterated by analysts at Needham & Company. They now have a USD 1 price target on the stock.

11/25/2014 – Amedica Co. had its “market outperform” rating reiterated by analysts at JMP Securities. They now have a USD 3 price target on the stock.

Amedica Co. has a 50 day moving average of 1.62 and a 200 day moving average of 2.15. The stock’s market capitalization is 12.21M, it has a 52-week low of 1.16 and a 52-week high of 12.59.

The share price of the company (AMDA) was down -0.70% during the last trading session, with a high of 1.47 and the volume of Amedica Co. shares traded was 334206.

View other investors thoughts on Amedica Co. on our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.